ArticleOncogene2021
Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway.
Deepti Bajpai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleOncogene2021
Deepti Bajpai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.